EVOKE PHARMA, INC. Form SC14D9C: Written communication by the subject company on a tender offer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-11-13: Form SC14D9C; Description SC14D9C; Document d27190dsc14d9c.htm.
- 2025-11-04: Form SC14D9C; Description SC14D9C; Document d47111dsc14d9c.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-11-13 | SC14D9C | SC14D9C | d27190dsc14d9c.htm | |
| 2025-11-04 | SC14D9C | SC14D9C | d47111dsc14d9c.htm |